Researchers make strides towards using genetically modified B cells for novel cell therapy
A team from the Seattle Children’s Research Institute (WA, USA) have recently made steps towards creating B cells that could be used in the treatment of diseases affecting children.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>